Category: Hepatitis C

Dec 23, 2013 03:06 pm | Deb Schmitz   Recent comments by Liberal MP Gerry Byrne regarding Pamela Anderson show the depth of stigma and misinformation about hepatitis C that still exists in Canada today. President of Pacific Hepatitis C Network and hepatitis C survivor Daryl Luster states, “Stigma related to hepatitis C, and the… Read more »

February 26 – 28, 2014, Richmond, BC  Registration Deadline: Friday, January 24th @4:00pm The Pacific AIDS Network (PAN) is excited to announce that we will be hosting a two and a half day conference for PAN member organizations and other allied/partner organizations, where frontline prevention, education, harm reduction, health promotion workers and program managers and… Read more »

CATIE’s HepCinfo Update 4.24

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”;} New and Noteworthy New study estimates cases of hepatitis B and C, but experts warn figures may be too low A new federal government… Read more »

CATIE HepCinfo Update 4.22

New and Noteworthy FDA advisory committee recommends the approval of simeprevir and sofosbuvir The Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously recommended the approval of two direct-acting antivirals for hepatitis C, simeprevir and sofosbuvir. The newer direct-acting antiviral medications are more effective, easier to take and have significantly fewer… Read more »

Pacific Hepatitis C Network – Annual General Meeting

  The Pacific Hepatitis C Network will be holding its Annual General Meeting on December 9, 2013 in Vancouver from 6 -8 pm. We will be announcing the location soon. This is a great opportunity to get together with other members of the Pacific Hepatitis C Network to share ideas, gain knowledge, and give input…. Read more »

Pacific Hepatitis C Network: Understanding Sofosbuvir

This is an exciting time in the evolution of HCV treatment in Canada.  New approved treatment in the near future will offer patients the opportunity to achieve the highest SVR and cure.  The hope is that the new drug Sofosbuvir will meet many current unmet needs and provide patients with the confidence to seek treatment… Read more »

Germs such as hepatitis B virus (HBV) and hepatitis C virus (HCV) infect and injure the liver. Long-term or chronic infection with either of these viruses can cause inflammation and healthy liver tissue is replaced with useless scar tissue. Prolonged increased levels of liver enzymes in the blood occur, suggestive of ongoing liver injury. Gradually… Read more »

September 2013 HepCBC Newsletter

Articles included: Liver Transplant Patients from Outside Vancouver face added hurdles URGENT request for Patient Input on SIMEPREVIR by Sept. 11th NEW Online HCV Support Community on “Health Unlocked” Portal NEW CIHR HIV-HCV Coinfection Mgmt & Treatment Guidelines World Hepatitis Day in BC, part II and WHD throughout Canada CATIE article on new HCV Drugs:… Read more »